Fish oil supplementation in patients with heterozygous familial hypercholesterolemia

Recenti Progressi in Medicina

Volumn 87, Issue 3, 1996, Pages 102-105

  Balestrieri, Gian Paolo ^a,c   Maffi, Viviana ^b   Sleiman, Intissar ^a   Spandrio, Sara ^a   Di Stefano, Ottavio ^a   Salvi, Andrea ^a   Scalvini, Tiziano ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Spedali Civili   (Italy)

Author keywords

familial hypercholesterolemia; fish oil; lipoprotein (a)

Indexed keywords

ESAPENT; FISH OIL; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; LIPID METABOLISM; MALE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CROSS-OVER STUDIES; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LOVASTATIN; MALE; MIDDLE AGED; PLANT OILS; SIMVASTATIN; TIME FACTORS;

EID: 0029896761     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Stone NJ, Levy RI, Fredrickson DS, Verten J. Coronary artery disease in 116 kindreds with familial type II hypercholesterolemia. Circulation 1974; 49: 476-88.
2. Goldstein JL, Brown HS. Familial hypercolesterolemia. In: The metabolic basic of inherited disease. 6th edition: Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. New York, 1989; 1215-250.
3. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein (a): a risk factor for myocardial infarction. Arteriosclerosis 1988; 8: 398-401.
4. Utermann G, Hoppichler F, Dieplinger H, Seed M, Thompson GR, Boerwinkle E. Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci USA 1989; 86: 4171-4.
5. Seed M, Hoppichler F, Reavelay D, et al. Relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype to coronary heart disease patients with familial hypercholesterolemia. New Engl J Med 1990; 322: 1494-9.
6. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989; 30: 785-807.
7. Hang HO, Dyerberg J. Plasma lipids and lipoprotein in Greenlandic west coast eskimos. Acta Med Scand 1972; 192: 85-94.
8. Leaf A, Weber PC. Cardiovascular effect of n3 fatty acids. N Engl J Med 1988; 30: 549-57.
9. Parks JS, Rudel LL. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis 1990; 84: 83-4.
10. Nestel PJ, Connor WE, Reerdon MF, Connor SL, Wong S, Borton R. Suppression by diets rich in fish oil of very low-density lipoprotein production in man. J Clin Invest 1984; 74: 82-9.
11. Friedewald WT, Levy RI, Fredrickson DS. Estima-tion of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
12. Holme I. An analysis of randomised trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 1990; 82: 1916-24.
13. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JL, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regime. JAMA 1990; 264: 3007-12.
14. Thiery J, Armstrong VW, Schleef J, Creutzfeldt C, Creutzfeldt W, Seidel D. Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr 1988; 66: 462-3.
15. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty. Arch Intern Med 1993; 153: 1595-601.
16. Nordoy A, Hatcher LF, Ullman DL, Connor WE. Individual effects of dietary saturated fatty acids and fish oil on plasma lipids and lipoproteins in normal man. Am J Clin Nutr 1993; 57: 634-9.
17. Davidson MH, Burns JH, Papasani VS, Conn ME, Dremman KB. Marine oil capsule therapy for the treatment of hyperlipidemic. Arch Intern Med 1991; 151: 1732-40.
18. Sawdset PM, Lund M, Norseth J, Abildgaoud U, Ose L. Treatment with hydroxy methylglutaryl coenzyme A reductase inhibitors in hypercholesterolemic induces changes in the components of the extrinsic coagulation system. Arterosclerosis Thromb 1991; 11: 138-45.
19. Hawsen JB, Lyngmo V, Svenson B, Norday A. Inhibition of exercise-induced shortening of bleeding time by fish oil in familial hypercholesterolemia (type IIA). Arteriosclerosis Thromb 1993; 13: 98-104.
20. Berg Schmidt E, Klausen IC, Kristensen SD, Lervang HH, Faergeman O, Dyerberg J. The effect of n3 polyunsaturated fatty acids on Lp(a). Clin Chim Acta 1991; 198: 271-6.
21. Gries A, Malle E, Wurm H, Kostner GM. Influence of dietary fish oils on Lp(a) levels. Thromb Res 1990; 58: 667-8.
22. Beil FU, Terres W, Orgass M, Heimer G. Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis 1991; 90: 95-7.